Massive pleural effusion and bronchopleural fistula in Wegener's granulomatosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 27, Issue 1, 2010, Pages 76-79

  Koyama, S ^a   Murakami, K ^a   Sakakibara, T ^a   Muramatsu, S ^a   Watanabe, M ^b   Miki, M ^c   Ebina, M ^a   Nukiwa, Toshihiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c Sendai Red Cross Hospital   (Japan)

Author keywords

Bronchopleural fistula; Massive lateral pleural effusion; Purpuric skin lesion; Wegener's granulomatosis

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BRONCHOPLEURAL FISTULA; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG BIOPSY; PLEURA EFFUSION; PLEURISY; PRIORITY JOURNAL; THORACOCENTESIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL ASPIRATION; WEGENER GRANULOMATOSIS;

ADULT; BIOPSY; BRONCHIAL FISTULA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PLEURAL DISEASES; PLEURAL EFFUSION; POSITRON-EMISSION TOMOGRAPHY; RESPIRATORY TRACT FISTULA; SKIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 77957591277     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
2. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener's granulomatosis: a clinical and imaging study of 77 cases. Chest 1990; 97: 906-12. (Pubitemid 20132316)
3. Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int 2007; 56: 87-96. (Pubitemid 46984236)
4. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
5. Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.J Rheumatol 2003; 30: 80-8.
6. Haubitz M, Schellong S, Göbel U, et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum 1998; 41: 1835-44.
7. Kallenberg CG. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 2008; 30: 29-36.
8. Abdou NI, Kullman GJ, Hoffman GS, et al. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J Rheumatol 2002; 29: 309-16.
9. Lohrmann C, Uhl M, Kotter E, Burger D, Ghanem N, Langer M. Pulmonary manifestations of Wegener granulomatosis: CT findings in 57 patients and a review of the literature. Eur J Radiol 2005; 53: 471-7. (Pubitemid 40312138)
10. Chauhan S, Chiu Y, Swift A, Griffiths K, Moots RJ. A hole in the roof. Am J Med 2008; 121: 960-2.
11. Sezer I, Kocabas H, Melikoglu MA, Budak BS, Ozbudak IH, Butun B. Spontaneous pneumothorax in Wegener's granulomatosis: a case report. Mod Rheumatol 2008; 18: 76-80.